AJO LP’s Collegium Pharmaceutical COLL Stock Holding History

AJO LP’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,220	Closed	-$101K	–	704
2020 Q1	$101K	Buy	+6,220	New	+$128K	﹤0.01%	595

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AJO LP's COLL Position: Q2 2020 in Review

AJO LP sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 6,220 shares — an estimated $101K sold.

AJO LP first reported a position in COLL in Q1 2020 and held it in 1 quarter. The position peaked at $101K in Q1 2020. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

AJO LP reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
AJO LP sold 6,220 Collegium Pharmaceutical shares in Q2 2020, an estimated $101K.
AJO LP first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 1 quarter.
AJO LP's Collegium Pharmaceutical position peaked at $101K in Q1 2020.
150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on AJO LP's 13F filing for Q2 2020, filed 12 Aug 2020.